Symbol
Gossamer Bio, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$0.94
Current price of the stock
$1M
Trading volume of the stock
$213.1M
Market capitalization of the company
Micro Cap
Category of market capitalization
36.95%
Long-term growth mean estimate
4.56
Mean analyst rating
708.05%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
3.64
Total debt to total equity ratio
6.74
Current ratio
100.00%
Gross profit margin
-357.80%
Operating profit margin
-357.80%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-336.87%
Pretax profit margin
-324.93%
Net profit margin
-56.90%
Measures profitability relative to shareholders' equity
-56.90%
ROE excluding intangible assets
-8.78%
Measures profitability relative to total assets
-12.25%
Measures profitability relative to invested capital
0.03
Asset turnover ratio
-
Inventory turnover ratio
1.44
Receivables turnover ratio
62.54
Average number of days it takes to collect receivables
-8.56
Measures valuation relative to earnings
-1.06
P/E based on future earnings estimates
2.02
Measures valuation relative to sales
3.94
Measures valuation relative to book value
-1.09
Measures valuation relative to operating cash flow
-1.09
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
